343. Petersen R. C., Touchon J. Consensus on mild cognitive impairment // Research and Practice in Alzheimers disease. Joint Meeting. Serdi Publisher. Paris. – 2005. – V. 10. – № 1. – P. 24–32.
344. Pfefferbaum A., Rosenbloom M. J., Adalsteinsson E., Sullivan E.V. Diffusion tensor imaging with quantitative fibre tracking in HIV infection and alcoholism comorbidity // Brain. – 2007. – V. 130. – Part 1. – P. 8–64.
345. Philbin M., Klaas P. Hearing and behavioral responses to sound in fullterm newborns // J Perinatol. – 2000. – V. 20. – № 12. – P. 68–76.
346. Phukan J., Pender N. P., Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis // Lancet Neurology. – 2007. – V. 6. – № 11. – P. 994–1003.
347. Prechtl H. F. R. The optimality concept // Early human development. – 1980. – V. 4–3. – № 2. – P. 201–205.
348. Prechtl H. F. R., Cioni G., Einspieler C. et al. Role of vision on early motor development // Development medicine and child neurology. – 2001. – V. 43. – № 1. – P. 198–201.
349. Radunovic A., Mitsumoto H., Leigh. Clinical care of patients with amyotrophic lateral sclerosis // Lancet. Neurology. – 2007. – V. 6. – № 10. – P. 913–925.
350. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells // Biol Psychiatry. – 2000. – V. 48. – № 4. – P. 766–777.
251. Ranganathan S., Williams E., Ganchev P. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis // J. Neurochem. – 2005. – V. 95. – № 5. – P. 1461–1471.
352. Raskind M. A., Peskind E. R., Wessel T. Galantamine in AD // Neurology. – 2000. – V. 54. – № 12. – P. 2261–2268.
353. Reisberg B. Functional assessment staging (FAST) // Psychopharmacol bulletin. – 1988. – V. 24. – № 4. – P. 653–659.
354. Reisberg B., Franssen E. H., Souren L. E. et al. Evidence and mechanisms of retrogenesis in Alzheimers and other dementias // Am J of Alzheimers disease and other dementias. – 2002. – V. 17. – № 4. – P. 202–212.
355. Riederer P. F., Tribl F., Grunblatt E. The early detection in Parkinson’s disease // Neurodegenerative Dis. 4 (Suppl 1). – 2007. – P. 110–111.
356. Rockwood K., Mintzer J., Truyen L. et al. Effects of a flexible galantamine dose in Alzheimers disease: a randomised, controlled trial // J. Neurol Neurosurg Psychiatry. – 2001. – V. 71. – № 4. – P. 589–595.
357. Rogers H., Carlos J., Lasprilla C.A. Retrogenesis theory in Alzheimers disease // Anales de psycologia. – 2006. – V. 22. – № 2. – P. 260–266.
358. Roman G. C. Diagnostic criterions of vascular dementia // Neurology. – 1993. – V. 43. № 1. – P. 250–256.
359. Roman G. C. Vascular dementia prevention: a risk factor analysis // Cerebrovasc Dis. – 2005. – Vol. 20 (Suppl 2). – P. 91–100.
360. Ryan R. M., Kuhl J., Deci E. L. Nature and autonomy // Devel. and Psychopathol. – 1997. – № 9. – P. 701–728.
361. Saffran J. R., Loman M. M., Robertson R. R. Infant long-term memory for music. – Ann NY Acad Sci, 2001. – V. 930. – № 6. – P. 397–400.
362. Saha S., Hsu C., Ferree A. et al. Genes associated with familial Parkinsons disease // Neurodegenerative Dis. 4 (Suppl 1). – 2007. – P. 15.
363. Sanai N., Mirzadeh, Berger M. S. Functional outcome after language mapping for glioma resection // N. Engl. J. Med. – 2008. – V. 358. – № 2. – P. 107–110.
364. Scarmeas N., Stern Y., Tang M. X. et al. Mediterranean diet, lifestyle factors, and risk for Alzheimers disease // Ann Neurol. – 2006. – V. 59. – № 11. – P. 912–921.
365. Scharre D. W., Shiovitz T., Zhu Y., Amatniek J. One-week dose titration of extended release galantamine in patients with Alzheimers disease // Alzheimers dementia. – 2008. – V. 4. – № 1 (Suppl 1). – P. 30–37.
366. Scherzer C. R., Eklund A. C., Morse L. J. et al. Molecular markers of early Parkinson’s disease based on gene expression in blood // Proc Natl Acad Sci USA. – 2007. – V. 104. – № 3. – P. 955–960.
367. Sivenius J., Nissinen J., Jolkkonen J. Long-term functional consequences of transient occlusion of the middle cerebral artery in rats: a 1-year follow-up of the development of epileptogenesis and memory impairment in relation to sensorimotor deficits // Epilepsy Res. – 2003. – Vol. 54. – № 1. – P. 1–10.
